Journal of Clinical & Experimental Dermatology Research
Open Access
ISSN: 2155-9554
+44 1478 350008
ISSN: 2155-9554
+44 1478 350008
John Vincent
Keynote: J Clin Exp Dermatol Res
L ow Level Laser Hair Therapy (LHT) is an essential tool in the medical management of hair loss. Leveraging the scientific research that has proven the benefits of LHT means you can offer a highly evolved and effective treatment for common Androgenetic Alopecia and inflammation of the scalp. Leveraging the scientific research that has proven the benefits of LHT means you can offer a high tech treatment for androgenetic alopecia and inflammation of the scalp that is a perfect complement to a trichological treatment regimen for scalp anomalies, as well as hair salon treatments and home use products recommended by Cosmetologists. Diagnosis and treatment of hair and scalp anomalies any non-drug, non-surgical treatment for common hair loss should include the use of low level laser light therapy (LHT). This modality utilizes �?¯�?¿�?½cool light energy�?¯�?¿�?½ to stimulate hair follicles (as opposed to powerful ablating lasers used to destroy hair follicle found in hair removal treatments).
John Vincent is one of the most knowledgeable and respected experts in the field of hair replacement today and is involved in many aspects hair loss solutions. He is certified Master of Hair Replacement techniques by the American Hair Loss Council. From the prompting of his physician colleagues, john witnessed the first commercial low level laser light hair therapy treatment (LHT) machine, first imported into the U.S. in the 90?s with healthy skepticism. He immediately saw the benefits of a no-risk, non-medical treatment that really worked for the one in four women and 50% of all men who suffer from thinning hair. John started working with the most prestigious LHT machine in 1995, the Sunetics? Corporation laser. His many contacts with hair transplant doctors led to his introducing the technology for hair restoration practices. Today, it is estimated that more than 50% of all such doctors use or advocate LHT for retaining ?native? hair and restoring weak, thinning hair. He has owned and operated his own laser hair growth clinic in San Luis Obispo, California, with his long-time friend and now medical advisor, dermatologist Bradley Kurgis, D.O. They have been successfully treating men and women with clinical and home use devices since 2007. Their informational website, www. jvhairgroup.com, is the most comprehensive collection of laser hair therapy knowledge to be found in one place. John is the North American distributor for the Laser Cap? Company, is a wholesale distributor for Theradome? and manufactures his own hand-held LHT device, the Nutreve? 35 diode personal laser. As President of Advantage Studios, Inc., a Florida-based corporation, he advised hair restoration physicians, hair replacement studios and the public n his website and many blog posts about the valid options to hair loss. His latest endeavor takes him back to his ?roots? in hair replacement systems, as the North American representative for Cesare Ragazzi Laboratories, and ultra-high-end hair replacement product hand made in Bologna, Italy, that is an Italian Medical Society-approved prosthetic device for hair loss . Because billions of dollars are wasted on worthless hair products each year, John prides himself as being an educator who has helped thousands of individuals regain an appearance they?re pleased with. He has conducted dozens of education seminars around the country for more than 15 years. John?s is the author of numerous articles about hair loss that have appeared in dozens of publications in the nation, contributed chapters in an international textbook about hair replacement techniques, has appeared in dozens of regional and national television news and interview programs, including Oprah Winfrey. For 10 years held a position contributing editor for the International Hair Journal, a quarterly news publication which reports on all types of hair loss, and includes surgical, medical and non-medical options, for which he still contributes articles and interviews.